Please assess the completion status of the following clinical trial:

Trial Title: Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Paramedics or reliable witnesses verify 5 minutes of either continuous seizure activity or of repeated convulsive seizure activity where the patient does not regain consciousness (operationally defined as meaningful speech or obeying commands) between seizures.~* Patient is still seizing at the time of paramedic treatment with study medications.~* Estimated weight equal to or greater than 13 kg.~* Subject to be transported to a RAMPART participating hospital.~Exclusion Criteria:~* Major trauma as the precipitant of the seizure~* Hypoglycemia (as defined by local EMS protocol or a glucose \< 60 mg/dL)~* Known allergy to midazolam or lorazepam~* Cardiac arrest or heart rate (HR) \<40 beats per minute~* Sensitivity to benzodiazepines~* Medical alert tag marked with RAMPART declined~* Prior treatment of this seizure with diazepam autoinjector as part of another study~* Known pregnancy~* Prisoners

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intramuscular (IM) anticonvulsant (Type: ACTIVE_COMPARATOR): This group gets active treatment with an anticonvulsant by the intramuscular route of administration.
- Intravenous (IV) anticonvulsant (Type: ACTIVE_COMPARATOR): This group gets active treatment with an anticonvulsant by the intravenous route of administration.

Based on this trial design, predict the completion outcome and termination type (if applicable).